3d Medicines, Inc.HKEX: 1244

3D Medicines Says Envafoimab Granted Orphan Drug Designation

· Issued by 3d Medicines, Inc.

3D Medicines Inc HKEX:1244:

  • ENVAFOIMAB GRANTED ORPHAN DRUG DESIGNATION

  • DESIGNATION FOR TREATMENT OF GASTRIC CANCER AND - GASTRO-ESOPHAGEAL JUNCTION CANCER INDICATIONS BY CHINA NMPA